Stereotactic Ablative Radiation for Systemic Therapy–naïve Oligometastatic Kidney Cancer

Raquibul Hannan,Michael Christensen,Alana Christie,Aurelie Garant,Ivan Pedrosa,Liliana Robles,Samantha Mannala, Chiachien Wang,Hans Hammers,Waddah Arafat,Kevin Courtney,Isaac A. Bowman,David Sher,Chul Ahn,Suzanne Cole,Hak Choy,Robert Timmerman,James Brugarolas

European Urology Oncology（2022）

引用 0|浏览2

暂无评分

摘要

This phase II trial provides prospective evidence that sequential stereotactic ablative radiotherapy to all sites of oligometastatic renal cell carcinoma, while the disease remains oligometastatic in a selected (and predefined) systemic therapy–naïve patient population, offers disease control in >90% of patients while maintaining health-related quality of life.

查看译文

关键词

Oligometastasis,Renal cell carcinoma,Stereotactic ablative radiotherapy,Stereotactic body radiation therapy,Stereotactic radiation

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要